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Background: Chronic lung disease of prematurity (CLD), also called bronchopulmonary dysplasia, is a 
major consequence of preterm birth but the role of the microbiome in its development remains 
unclear. We, therefore, assessed the progression of the bacterial community in ventilated preterm 
infants over time in the upper and lower airways, and assessed the gut-lung axis by comparing the 
upper and lower airways bacterial communities with the stool findings. Finally, we assessed if the 
bacterial communities were associated with lung inflammation to suggest dysbiosis. 
Methods: We serially sampled multiple anatomical sites including the upper airway (nasopharyngeal 
aspirates, NPA), lower airways (tracheal aspirate fluid, TAF, and bronchoalveolar lavage fluid, BAL) 
and the gut (stool) of ventilated preterm-born infants. Bacterial DNA load was measured in all 
samples and sequenced using the V3-V4 region of the 16S rRNA gene 
Results: From 1,102 (539 NPA, 276 TAF, 89 BAL, 198 stool) samples from 55 preterm infants, 352 
(32%) amplified suitably for 16s RNA gene sequencing. Bacterial load was low at birth, quickly 
increased with time but was associated with predominant operational taxonomic units (OTUs) in all 
sample types. There was dissimilarity in bacterial communities between the upper and lower airways 
and the gut with a separate dysbiotic inflammatory process occurring in the lower airways of infants. 
Individual OTUs were associated with increased inflammatory markers.  
Conclusions: Taken together, these findings suggest that targeted treatment of the predominant 
organisms, including those not routinely treated such as Ureaplasma spp., may decrease the 




Chronic lung disease of prematurity (CLD), also called bronchopulmonary dysplasia (BPD), is a major 
consequence of preterm birth being influenced by many early life [1]. We have previously shown 
that the presence of predominant bacteria is associated with the development of CLD most likely via 
the pulmonary inflammatory pathway [2], [3]. Furthermore, specific organisms such as Ureaplasma 
are also strongly implicated in the pathogenesis of CLD [4], [5] with some evidence suggesting that 
eradication of Ureaplasma may decrease rates of CLD [6]. In the term-born infant, early bacterial 
colonisation of the upper respiratory tract appears to occur within minutes of birth [7] or possibly 
antenatally but the natural history of colonisation of the upper and lower airways of the preterm 
lung is less clear [8]. A recent systematic review [9] investigating the development of the airway 
microbiome in preterm infants raised more questions about the bacterial colonisation of the 
preterm lung than have been answered with existing studies; no study has investigated the links 
between the upper airways and the gastrointestinal tract, i.e. the proposed gut-lung axis, with the 
lower airways of preterm infants. The included six studies [10]–[15] showed variable findings e.g. 
one reported progression from Proteobacteria to Firmicutes but another showed reverse 
progression. To provide a more comprehensive assessment of the bacterial community in preterm 
infants who are at risk of developing CLD, (a) we serially studied multiple anatomical sites, including 
obtaining tracheal aspirate fluid (TAF) and bronchoalveolar lavage (BAL) fluid from ventilated 
preterm infants to assess the tracheal and lower airways respectively; nasopharyngeal aspirates 
(NPA) and stool samples to assess the progression of the bacterial community in ventilated preterm 
infants over time in the upper and lower airways. (b) We assessed the microbial relationship 
between the stool and upper/lower airways, i.e. the gut-lung axis, for which there are no studies 
thus far in term or preterm-born infants. (c) We also assessed the relationship between the bacterial 
communities and clinical factors including mode of delivery, sex, clinical site of sampling and effect 
of antibiotics. (d) Finally, we measured proinflammatory cytokines interleukin (IL)-6 and -8 in all 
samples types and related the findings to the bacterial communities observed.  
 
Methods 
Sample Collection  
Preterm infants of ≤32 weeks’ gestation were recruited from two tertiary regional neonatal intensive 
care units in the United Kingdom. TAF and NPA were collected at the time of routine endotracheal 
tube (ETT) suctioning. BAL samples were collected as per our previous studies [2], [16] and according 
to the European Respiratory Society taskforce guidelines [17] at the time of routine ETT suctioning as 
described in the online supplement. TA, BAL and NPA samples were collected daily during the first 
week then twice weekly or until extubation, whichever occurred earlier. Stool samples were 
collected weekly until 28 days of life. Ethical approval (Ref 14/WA/0190) was obtained from the 
Wales Research Ethics Committee 2 and written informed consent was obtained from the parents. 
 
DNA Extraction, Bacterial Load and Sequencing 
DNA extraction, bacterial load and 16S sequencing are described in more detail in the online 
supplement. Total bacterial load was quantified by a qPCR assay based on published protocols [18] 
amplifying the V3-V4 region of the 16S rRNA gene. Purified PCR product were quantified and 
samples with adequate amplification pooled to create an amplicon library. Separate libraries were 
prepared for TAF, BAL, NPA and stool samples. Each library was sequenced on an Illumina MiSeq 
device [19].   
 
Data Analysis 
Mothur v1.39.5 [20] was used to process the sequencing data, excluding chimeric sequences and 
low quality reads and to group the DNA sequence data into OTUs at 3% dissimilarity. Samples with 
less than 1,000 reads were excluded. The reference database from the Ribosomal Database Project 
[21] was used for phylogenic identification of each OTU from kingdom to genus level. Samples were 
rarefied to 1,000 reads per sample prior to further analysis. Statistical analysis was performed within 
R v3.4.2 [22] using Phyloseq v1.20.0 [23] and Vegan [24]. STAMP v2.13 [25] was used to compare 
bacterial profiles between different groups. Datasets were merged at genus level for comparison of 
microbiome profiles from different anatomical sites. Samples with a single OTU representing >50% 
reads were considered to contain a predominant organism.  
 
Results 
1,102 samples were collected from 55 preterm infants born at ≤32 weeks’ gestation (median ± IQR: 
26.0, 24.7 to 27.5 weeks) during the first 28 days of age including 539 NPA, 276 TA, 89 BAL and 198 
stool samples. The demographics are shown in Table 1 including comparison of data between the 
two recruitment centres (University Hospital of Wales, UHW; and North Bristol Trust, NBT). 
Marginally more immature infants were recruited at NBT although the difference was not 
statistically significant (26.8 vs 25.9 weeks, p=0.07). More patent ductus arteriosus were identified at 
NBT since they screen for this condition. As expected with recruitment of only ventilated preterm 
infants, most infants developed CLD defined using the NIHD definitions [26] with 84% developing 
moderate to severe CLD. 
 
352 (32%) of the 1,102 samples were successfully sequenced for 16S rRNA genes with the greatest 
success rate for stool (73%) samples and least for TAF (17%) samples (Figure 1). Bacterial load was 
low at days 1-3 with only 1.1% and 6.7% of TAF and NPA samples successfully sequenced for 
bacterial 16S rRNA genes with a success rate of 35.7% for stool samples suggesting a low bacterial 
load at birth especially in the upper airways. Although 19.4% of BAL samples were available for DNA 
sequencing, a lower threshold for bacterial DNA sequencing was used for these samples 
(concentration of DNA post-PCR amplification of 0.3ng/µL for TAF and NPA, 0.1ng/µL for BAL, and 
0.5ng/µL for stool). Bacterial load peaked at day 4-7 for BAL and TAF samples and at days 8-14 for 
NPA and stool samples. Interestingly, a similar pattern of increase was observed for the TAF and BAL 
samples, and for the stool and NPA samples (Figure 1).  
 
After low quality reads and chimeric sequences were removed, the mean reads were 109,457 (range 
8,665 to 426,696) for TAF samples; 44,548 (27 to 177,875) for BAL samples; 60,295 (5,951 to 
222,539) for NPA samples; and 59,329 (1 to 481,757) for stool samples with 0, 2, 0 and 39 samples 
removed respectively for reads of <1,000 per sample. The maximum reads for negative controls 
were 7,558, 588, 580 and 206 respectively with one TAF sample discarded due to co-clustering with 
a negative control sample. 
 
The majority of phyla in all samples, as shown in Figure 2 and summarised in Online Figure 1, were 
Proteobacteria and Firmicutes; Tenericutes were also present particularly in TAF and BAL samples 
and to a lesser extent in NPA samples; Bacteroidetes were noted in stool samples with lesser 
presence in NPA, TAF and BAL samples. The phyla TAF and BAL pattern, over the first month of life, 
remained static with a mean relative abundance  ~40-50% of Proteobacteria; whilst Proteobacteria 
in NPA and stool samples increased from a mean relative abundance of 15% in NPA and 30% in stool 
in the first week of life to 46% and 55% respectively by the third/fourth weeks of age (Figure 2, 
summarised data shown in Online Figure 2). Most samples contained a single dominant phylum 
(>50% of reads from a single phylum). At genus level, Staphylococcus, as shown in Figure 3, was the 
dominant genus (>50% of reads from a single genus) in nearly 30% of all samples with Klebsiella, 
Escherichia, Unclassified Enterobacteriaceae, Enterococcus and Serratia predominating in 35% and 
the Tenericutes Ureaplasma and Mycoplasma for 5.2% all of samples. Whilst Proteobacteria 
increased and Firmicutes decreased with age especially in NPA (Proteobacteria p<0.001, Firmicutes 
p=0.008, Kruskal-Wallis test with Benjamini Hochberg FDR) and stool samples, there was no obvious 
patterns of change at genus level although dominance of the above-mentioned genera was evident. 
Both at genus and OTU level, a dominant genus/OTU was present in most sample with 31/34 (91%), 
43/47 (92%), 122/126 (97%) and 130/145 (90%) of BAL, TAF, NPA and stool samples respectively 
having >50% of their reads for a single dominant OTU as shown in Figure 3. 
 
Interesting, each infant had their own individual bacterial pattern which differed between individual 
infants and also between anatomical sites. (Figure 4A and 4C). Since there was no overall pattern 
over time, we collated the samples from each anatomical site for further analyses. The number of 
observed genera and Chao1 index were different between the sample types being greater in the BAL 
and TAF samples (p<0.001 for both indices) (Figure 4B) but not for Shannon or Simpson’s alpha 
diversity indices (data not shown) when calculated at genus level. However, there were no 
differences noted for observed OTUs or Chao1 when calculated at OTU level (Figure 4B). This data of 
similar indices for genera and OTU level for BAL and TAF samples suggest that individual OTUs 
predominate in these samples but the increase in indices between the genera and OTUs for NPA and 
stool samples suggest greater richness in these samples. Beta-diversity analysis for TAF and NPA 
samples did not show any significant pattern over time (Online Figure 4).  
 
When bacterial communities were examined between the four sample types by PERMANOVA, all 
differed significantly from each other as shown in Figure 4C: BAL vs TAF; BAL vs NPA; BAL vs stool; 
TAF vs NPA; TAF vs stool; and NPA vs stool; all p<0.01. 
 
Delivery mode influences early colonisation across many anatomical sites in term new-born infants 
and in the limited data for preterm infants in stool samples [7], [27], [28]. Mode of delivery was 
associated with an increase in Gram-negative genera (Acinetobacter (p=0.04) and marginally with 
Pseudomonas (p=0.06)); Mycoplasma (p=0.04) in TAF samples; and Serratia (p=0.01) in NPA from 
infants delivered vaginally. For infants delivered by caesarean section, Staphylococcus were 
increased in NPA (p=0.02), and marginally in TAF samples (p=0.056) (Online Figure 2A). However, sex 
did not influence TAF or NPA bacterial communities (Online Figure 2B). A significant difference for 
bacterial community structure was noted between the recruitment centres (p<0.05) (Online Figure 
2C).  This may be partially explained by the outbreak of Acinetobacter at one site resulting in greater 
Acinetobacter observed at that recruitment centre. 
   
At both recruiting centres the initial prophylactic antibiotic regimen of benzylpenicillin and 
gentamicin was altered according to subsequent microbiological assessments. 219/276 (79%) TAF 
and 335/539 (62%) NPA samples were taken while the infants were receiving antibiotic therapy 
(Online Figure 3). Samples taken when not on antibiotics were significantly more likely to be 
successfully sequenced for 16S rRNA genes than samples taken whilst on antibiotics (OR=2.91 (95% 
confidence interval 1.48, 5.73), p=0.002 for TAF; and 3.10 (2.05 to 4.67), p<0.0001 for NPA samples). 
Antibiotics did not affect alpha diversity in successfully sequenced TAF and NPA samples suggesting 
that they globally suppressed bacterial growth rather than suppressing specific species. 
Nevertheless, antibiotics were associated with increased proportion of Tenericutes (p=0.03), most 
likely due to Mycoplasma which were marginally increased (p=0.059) in TAF samples compared to 
the no antibiotic group. 
 
Since a single OTU predominated (>50% of reads) in most of the successfully sequenced samples, 
potentially those samples with greater initial biomass,  we measured IL-6 and IL-8 in all samples to 
evaluate if successful bacterial DNA detection in samples was associated with an inflammatory 
response. IL-6 and IL-8 were largely undetectable in the NPA and faecal fluid extracts but were noted 
in considerable quantities in the BAL and TAF samples if they could be sequenced as shown in Figure 
5A in TAF and BAL samples: TAF successful sequencing vs unsuccessful sequencing samples: IL-6: 
1,222 (534, 3,224) vs 539 (217, 1,377); and IL-8: 26,383 (3,460, 51,740) vs 9,031 (2,535, 20,511) 
pg/ml; and BAL: IL-6 3,629 (2,029, 8,538) vs 1,213 (485, 2,459); and IL-8 80,689 (12,303, 196,477) vs 
9520 (3,060, 18,572) pg/ml, all p<0.001. We next tracked the dynamic changes in individual infants 
as shown in Figure 5B. Each individual infant had episodic increases in IL-6 and IL-8 which 
corresponded to increased bacterial load and to presence of predominant OTUs. From 20 episodic 
TAF IL-8 peaks of >50,000 pg/ml observed in 19 infants, 13 episodes (65%) were associated with 
presence of bacterial DNA within 24 hours of the peak cytokine concentration. Both IL-6 and IL-8 
showed peak concentration at 7 days of age as we have shown previously in infants developing 
CLD[2], [3], [16] (Figure 5C). Finally, the predominance of OTUs such as Acinetobacter, unclassified 
Enterobacteriaceae and Mollicutes including Mycoplasma and Ureaplasma were strongly associated 
with the greatest increases in IL-6 and IL-8 in BAL, being several-fold greater than in samples which 
could not be sequenced (Figure 5D).  
 
Discussion 
In this comprehensive longitudinal study, we have studied the upper and lower airways of preterm 
infants who were at risk of developing CLD and related the findings to serial stool samples to assess 
the gut-lung axis. We have made several important observations: firstly, low bacterial DNA load was 
noted in the first few days of life which increased during the first month of life. Secondly, all 
anatomical sites sampled including the upper and lower airways had their own distinct patterns of 
bacterial community, in most cases with the presence of a dominant OTU, and with dissimilarity 
between the anatomical sites. Thirdly, bacterial communities in the lower airways were associated 
with an active proinflammatory phase. Fourthly, specific OTUs were associated with marked 
increases in proinflammatory cytokines. 
 
Overall, from 1,102 samples, 31.9% (352) were satisfactorily amplified for bacterial sequencing. 
Bacterial load was low in all samples during the first three days of life but peaked at days 4-7 of life 
in BAL and TAF samples, and at days 8-14 in stool and NPA samples. Bacterial acquisition is most 
likely to be from the mother with vaginally associated microbes including Tenericutes predominating 
in vaginally delivered infants, and Staphylococcus predominating when delivery was by caesarean 
section.  
 
At phyla level, the NPA and stool samples changed similarly over time with an increase in 
Proteobacteria which remained relatively static in the BAL/TAF samples. The Tenericutes, 
Ureaplasma and Mycoplasma, were mainly confined to the lower airway samples with only some 
presence in NPA samples but were almost absent from stool samples. In contrast, Acinetobacter was 
present in stool and in NPA samples but not in lower airway samples reflecting the outbreak in that 
unit. Almost all samples had a predominant OTU, with >90% of samples having a predominant OTU 
of >50% of reads with Staphylococcus, Mycoplasma, and Ureaplasma predominating especially in 
the lower airways. Interestingly, all infants had their own bacterial pattern with little overlap 
between the sample types suggesting an active infective episodic process. Significant differences 
were present in the community structure of the samples from each anatomical site as was shown by 
the PERMANOVA analysis. Alpha diversity indices estimating richness showed greater number of 
genera present in BAL and TAF than in NPA or stool samples, but the differences disappeared at OTU 
level suggesting greater richness at OTU level for NPA and stool samples. Since measures of 
evenness (Shannon diversity index) did not show a difference between the sample sites, the data 
suggest that the degree of dominance of a single OTU was no different between anatomical sites. 
Differences between the NPA and BAL/TAF samples may be partly explained by the presence of an 
uncuffed ET tube which partially separates the upper and lower airways. Obtaining lower airways 
samples from non-ventilated preterm or term new-born infants is not possible thus limited data 
exist for the microbial evolution of the lower airways [29].  
 
As previously observed for term-born infants, mode of delivery was associated with increased 
proportion of Staphylococcus in NPA (p=0.022) and marginally in TAF (p=0.056) in those who were 
delivered by caesarean section and increased Mycoplasma (p=0.039) and Acinetobacter (p=0.042) in 
TAF samples and Serratia (p=0.008), Ureaplasma (p=0.024) and Corynebacterium (p=0.028) in NPA 
samples from vaginally delivered infants. Sex did not affect the bacterial colonisation but the centre 
at which the sample was obtained did influence the results. These results may be partly explained by 
the outbreak of Acinetobacter in one unit but the differences between the two centres remained in 
sensitivity analyses when the infants colonised with Acinetobacter were removed thus suggesting 
that the local environment or local personnel appear to influence colonisation in addition to the 
maternal milieu. Antibiotics, as expected, decreased bacterial load with fewer samples being 
suitable for bacterial gene sequencing. The diversity and number of OTUs were, however, similar 
when the babies were on or off antibiotics. Tenericutes presence was increased in TAF samples 
(p=0.03) and a trend towards Tenericutes increased in NPA samples (p=0.059) in the antibiotic 
group.  
 
Most interestingly, we noted several fold differences in IL-6 and IL-8 concentrations in BAL and TAF 
when bacterial sequencing was possible against when it was not. Our data suggest that an infective 
dysbiotic environment is occurring in the lungs of babies who are at risk of developing CLD. Low 
biomass samples may have lower cytokine concentrations due to dilution caused by variation in 
volume of samples returned. However, as per our previous observations, the collated data for IL-6 
and IL-8 showed a peak concentration of both cytokines at approximately 7 days of age [2], [3], [16]. 
Increased cytokine peaks associated with predominant OTUs in each individual infant suggest an 
infective process. This was further supported by the marked increases in TAF IL-6 and IL-8 for 
individual OTUs confirming that infective processes were common in the lungs of babies who are at 
risk of developing CLD. 
 
 Taken together, these data suggest that both the bacterial community and pulmonary inflammation 
are potential targets with antimicrobials such as azithromycin which has both anti-infective and anti-
inflammatory activities to decrease rates of CLD [6].  
 
There are several limitations to this study, most notably the presence of an ET tube to support the 
infant’s respiratory system. Most importantly, this precludes the acquisition of samples from 
“healthy” preterm- and term-born infants which is not ethically possible. The presence of an ET tube 
may physically separate the lower and upper airways but, despite prolonged ventilation in many 
infants, we noted separate processes in the upper and lower airways and in the GI tract. The 
strength of the study is the large number of samples from multiple anatomical sites obtained 
longitudinally making this by far the largest study of preterm infants. Furthermore, we have related 
the findings between recruitment centres and with the inflammatory processes occurring in the 
lungs of infants at risk of developing CLD.  
 
In summary, bacterial load was low at birth but quickly increases and microbes are most likely to be 
acquired from the mother. There was dissimilarity between the upper and lower airways and the gut 
in bacterial community structures with a separate dysbiotic inflammatory process occurring in the 
lower airways of infants at increased risk of developing CLD. Additionally, the pulmonary 
inflammatory processes were occurring despite the infants being on antibiotics suggesting that 
microbes not susceptible to routinely used antibiotics such as Ureaplasma and Mycoplasma may 
predominate and potentially provide a therapeutic target to decrease the development of CLD in 
preterm-born infants [6].  
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Table 1 – Demographics of recruited preterm infants from two sites  
 





(UHW vs NBT) 
Number of infants 55 20 (36%) 35 (64%) - 
Number of samples 
Nasopharyngeal aspirates 
Tracheal aspirate fluid  



























Sex (male) 36 (65%) 12 (60%) 24 (69%) 0.73 
Gestation (weeks) 26.0 (24.7-27.5) 26.8 (25.3-29.4) 25.9 (24.7-26.6) 0.07 
Birth weight (g) 764 (680-918) 835(695-1082) 746 (677-880) 0.16 
Antenatal steroids 51/55 (93%) 18/20 (90%) 33/35 (94%) 0.18 
Delivery mode (percent 
vaginal delivery) 
29 (53%) 10 (50%) 19 (54%) 0.98 
Multiple births 17 (31%) 6 (30%) 11 (31%) 1 
 
Maternal antibiotic in labour 14 (25%) 4 (20%) 10 (29%) 0.70 




35/35 (100%) 0.27 
 























Survival to discharge 47 (85%) 17 (85%) 30 (86%) 1 
Ventilation days 17 (4-32.5) 25 (3.5-37.8) 17 (5-28.5) 0.55 
Non-invasive ventilation days 47 (24.5-64.5) 38(19.8-53.5) 55(31.5-66) 0.14 



















Patent ductus arteriosus 40 (73%) 11 (55%) 29 (83%) 0.06 
Initial breast milk 









Medians  interquartile ranges are shown unless otherwise stated. UHW – University Hospital 
Wales, NBT – North Bristol Trust. Necrotizing Enterocolitis Grades were categorized according to 
Bell’s staging criteria and CLD severity according to ref: 16.  
 
 

































































Figure 1. Total bacterial load in the gut and airways of preterm infants. (A) Change in total bacterial 
load over time shown for the four anatomical sites BAL (Bronchoalveolar Lavage), NPA 
(Nasopharyngeal Aspirate), TAF (Tracheal Aspirate Fluid) and stool samples. BAL, TAF and NPA 
samples were measured in copies of the 16S RNA gene per ml of supernatant. Stool samples were 
measured in copies of the 16S DNA gene per mg of stool. Mean ± standard errors shown. (B) Table 
showing the number of samples available at each time point for each sample type, and the percent 
of the samples from which the 16 rRNA gene could be successfully amplified at each time point of 



























































































Figure 2 – Microbiome analyses for each sample site shown by phyla 
1-7 15-21 8-14 
1-7 15-21 8-14 

















































Figure 2. Microbiome analyses for each sample site shown by phyla. The relative abundance of the predominant phyla of the preterm infant is shown for 
each time period. Each bar represents an individual sample with relative abundance shown after all OTUs from each phylum were combined and averaged. 
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Figure 3 – Microbiome analyses for each sample site shown at genus level 
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Figure 3. Microbiome analyses for each sample site shown at genus level.  
The relative abundance of the predominant genera of the preterm infant is shown for each time 
period. Each bar represents an individual sample with relative abundance shown after all OTUs from 
each genus were combined and averaged. Abbreviations: BAL – Bronchoalveolar Lavage, NPA – 
Nasopharyngeal Aspirate, TAF – Tracheal Aspirate Fluid. 
 
  
Figure 4 – Microbiome community structure between sample sites 
TAF BAL Stool NPA a. 
c. 
b. 
Genus level OTU level 
Figure 4. Microbiome community structure between sample sites. (A) NMDS plots for individual 
babies for each sample site shown. Each coloured polygon joins all samples from an individual infant. 
(B) Alpha diversity of observed and Chao1 shown at genus and OTU level. (C) NMDS plot showing the 
relationship between the bacterial community between the anatomical sites. PERMANOVA showed 
significant differences between the BAL vs TAF, BAL vs NPA, BAL vs Stool, TAF vs NPA, TAF vs Stool, 
NPA vs Stool using Bonferroni correction, all p<0.01. Abbreviations: BAL – Bronchoalveolar Lavage, 
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Figure 5 - Association of the lower airway microbiome with markers of inflammatory  





Figure 5. Association of the lower airway microbiome with markers of inflammatory. (A) Log10 
scale for interleukin-6 (IL-6) and interleukin-8 (IL-8) in tracheal aspirate fluid (TAF) and 
bronchoalveolar lavage (BAL) fluid samples for samples where bacterial sequencing was positive or 
negative. (B) Shows the relationship between IL-6 (grey), IL-8 (purple), antibiotic treatment (blue) in 
upper graph and bacterial load (black) and bars showing genus constituents in three individual 
babies (Baby 1 – 3). Generally, parallel increases and decreases were observed for all markers 
despite antibiotic treatment. (C) Averaged IL-6 and IL-8 in TAF samples shown for each time point 
regardless of bacterial presence showing a peak of both cytokines at day 7 as previously shown2,3,19. 
Mean ± SEM shown. (D) Association is shown between the presence of IL-6 and IL-8 in BAL samples 
with specific OTUs showing increased IL-6 and IL-8 if an OTU was identified when compared to the 
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Collection of Clinical Samples 
BAL fluid was collected as previously described1-3. Briefly, with the infant supine, with the head 
turned to the left, a Fr6 catheter was advanced through the ET tube until resistance was felt and 
1ml/kg of sterile saline instilled. The fluid was then aspirated. After allowing the baby to recover, the 
procedure was repeated, and the samples pooled. The BAL samples were centrifuged at 10,000g for 
10 mins within 60 minutes to separate the cells and supernatant before storage at -80oC.  
TA samples were collected at the time of clinically indicated routine endotracheal tube suctioning 
and the collection catheter flushed with 2ml of sterile saline. Nasopharyngeal aspirates (NPA) 
samples were collected by suctioning mucous from the nasopharynx and flushing the collected 
sample with 2 ml of sterile saline.  Collected TAF and NPA samples were initially frozen at -20oC then 
transferred without thawing to -80oC.  TA, BAL and NPA samples were obtained daily for the first 
week of life then twice weekly until 28 days of age or until extubation, whichever occurred earlier. 
Stool samples were collected twice weekly until 28 days of age. Control samples were obtained 
flushing sterile saline through the same suction catheters used to collect samples. 
 
DNA Extraction 
TAF and NPA samples were thawed on ice and centrifuged at 10,000g for 10 mins to separate the 
cell pellets and supernatant. Cell pellets from all respiratory samples were resuspended in 0·5ml of 
DNA extraction buffer containing 5M guarnodine thiocyanate. The samples were bead beaten with 
0·1mm zirconia beads for 3 x 30 seconds at 6·5m/s using a FastPrep 24 device (MP Biomedicals, CA, 
USA) and placed on ice for 5 mins between each episode. Samples were then loaded into a Maxwell 
16 automated DNA extraction device (Promega UK, Southampton, UK) using the tissue DNA 
extraction kit. DNA was eluted into 300ul of the supplied elution buffer.  Stool samples were thawed 
on ice for 1 hour before being weighed before homogenising. The homogenate was then 
centrifuged, and DNA extracted from the faecal pellet using the Qiagen Stool Mini Kit (Qiagen, 
3 
 
Hildenberg, Germany) as per manufacturer’s instructions, with the following optimizations. 2 ml of 
InhibitEX buffer was added to the faecal pellet and vortexed continuously for 1 minute, or until the 
sample was fully homogenous. 1·5 ml of this solution was then transferred into a 2 ml 
MPBiomedicals Lysing Matrix tube E, which contained 1·4 ceramic spheres, 0·1 mm silica spheres 
and one 4 mm glass bead. The tubes were then homogenised in the FastPrep 24 instrument for 60 
seconds at 5·0 m/s. This process was repeated 3 times with 5-minute incubations on ice between 
each beating. The samples were then heated for 5 minutes at 70oC in a heat block. The heated 
samples were then vortexed for 15 seconds, before being centrifuged at 20,000 x g for 1 minute. 200 
µl of the supernatant was then taken forward into the remainder of the protocol.  
 
Quantification of Bacterial Load 
Total bacterial load was quantified by a qPCR assay based on published protocols4 amplifying the V3-
V4 region of the 16S rRNA bacterial gene. Primers sequences used were: forward  5′- 
CCTACGGGDGGCWGCA-3′ and reverse:  5′- GGACTACHVGGGTMTCTAATC -3′. The TaqMan probe 
sequence was (6FAM) 5′-CAGCAGCCGCGGTA-3′ (MGBNFQ). 2·5 µL of DNA was added to a total 
reaction of 10 µL. The thermal cycling protocol was heating for 3 min at 50°C for UNG treatment, 
then 10 min at 95°C for Taq activation followed by 40 cycles of 15s at 95°C for denaturation and 1  
min at 60°C for annealing and extension. A standard curve was generated in each assay using serially 
diluted E. Coli genomic DNA. DNA used generating standard curves was extracted from pure growths 
of E.Coli organisms with DNA quantification using a Cubit analyser.  Samples, standards and controls 
were run in triplicate and a set cT threshold maintained for each run of the experiment.  
 
Sequencing 
The V3-V4 region of the 16S rRNA gene was amplified from each DNA extract using the Taq Core PCR 
kit (Qiagen, Hilden, Germany) with forward and reverse primers at 0,5µM each. Barcoded primers 
were designed according to Kozich et al. 5 to include Illumina adapter, an 8 nucleotide barcode 
4 
 
sequence, a 10 nucleotide pad sequence, a 2 nucleotide linker, and a gene-specific primer:: 341F-
CCTACGGGNGGCWGCAG or  805R-GACTACHVGGGTATCTAATCC. (Sigma-Aldrich, Dorset, UK) and 
used to amplify each DNA sample using different barcode combination. The cycling conditions were 
as follows: initial denaturation at 950C for 3min, 30 cycles of 950C for 30 sec, 540C for 30 sec,720C for 
10 min and a final extension at 720C for 10 min.  Purification of the PCR products was achieved using 
AMPure beads (Beckman Coulter (UK), High Wycombe, UK). 
 
Purified PCR product were quantified using the Qubit dsDNA High Sensitivity Assay Kit 
(ThermoFisher, Leicestershire, UK), and pooled to create a library with approximately equal 
concentrations of 16S rRNA amplicons from each sample. Separate libraries were prepared for TAF, 
BAL, NPA and stool samples. Pooled libraries were quality and quantity checked using the The High 
Sensitivity D1000 ScreenTape assay (Agilent Technologies, CA, USA) and a NEBNEXT library 
quantification kit (New England Biolabs).  Each library spiked with 10% PhiX was sequenced on an 
Illumina MiSeq using the Reagent Kit V2 with 500 cycles (Illumina UK, Cambridge, UK) and custom 
primers as previously described5. 
 
Data Analysis 
STAMP (Statistical Analysis of Metagenomic Profiles) software was used to produce error bar plots 
using White’s test with Benjamini-Hochberg False Discovery Rate method used to correct for 


























































































Day -7, n= 27 Day 15-28, n=83 Day 8-14, n = 35 
Age (days) 




















Observed species P=0·673 Shannon P=0·881 Inverse Simpson P=0·966 
a. Mode of delivery 
b. Gender 













Online Figure 3 – The effect of antibiotics on tracheal aspirate fluid (TAF) and nasopharyngeal aspiration (NPA) 
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Online Figure 4: Beta-Diversity Changes over time 
 
A - NPA 
 
 







Online Figure 1. Averaged microbiome data for each sample site shown by phyla. The relative 
abundance of each phylum averaged for all samples at each time-point for each sample type is 
shown. Abbreviations: BAL – Bronchoalveolar Lavage, NPA – Nasopharyngeal Aspirate, TAF – 
Tracheal Aspirate Fluid. 
 
Online Figure 2. The effect of mode of delivery, gender and centre of recruitment on the upper 
(NPA) and lower airway (TAF) microbiome. Shown are the effect of the (A) mode of delivery, (B) 
Gender and (C) centre from which sample was collected on bacterial OTUs in upper (NPA) and lower 
(TAF) airway samples. In addition, alpha and beta diversity shown for sample site (red NBT, North 
Bristol Trust, UHW, University Hospitals of Wales).  
 
Online Figure 3. The effect of antibiotics on tracheal aspirate fluid (TAF) and nasopharyngeal 
aspirate (NPA) samples. (A) percentage of samples which had sufficient for bacterial 16s rRNA gene 
sequencing, whilst on or off antibiotics. (B) Alpha diversity shown for TAF samples when taken when 
the infant was or was not on antibiotics. (Alpha diversity for NPA similarly similar between the 
antibiotic and no antibiotic samples.)  (C) shows the effect of antibiotics on the lung bacterial 
community at the phylum level and (D) at genus level, for the most abundant 7 genera, for samples 
taken whilst on or off antibiotic treatment.  
 
Online Figure 4: Beta-diversity changes over time 
Changes in Bray-Curtis Dissimilarity index in samples from individual infants by week of life. Bray-
Cutis index calculated between each consecutively collected successfully sequenced sample from 
each infant. The median day between the samples used to allocate week of life. For weeks with 
more than 1 beta diversity value calculated the average value was taken. Grey lines represent the 
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results for individual infants and the bold red line shows the average from each week. A= 
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